The Clinical Sequencing Evidence-Generating Research (CSER) consortium is a national multi-site research program funded by the National Human Genome Research Institute (NHGRI), the National Cancer Institute (NCI), and the National Institute on Minority Health and Health Disparities (NIMHD).
Consent CodesGRU, HMB
DiseasesHereditary Cancer Risk, Suspected Genetic Disorder, Healthy Adults, Structural Anomaly
Study DesignClinical Trial, Family/Twins/Trios, Case Set, Clinical Genetic Testing, Parent-Offspring Trios
Data TypesWhole Exome, Targeted Panel, Whole Exome Sequencing, Whole Genome, 0